Szlak Daniel sold $209K of SBS

Szlak Daniel (Chief Financial Officer) sold 7,381 shares of COMPANHIA DE SANEAMENTO BASICO DO ESTADO DE SAO PAULO-SABESP (SBS) at $28.30 ($0.21M total) across 2 trades on 2026-06-15.

Original reporting
SEC EDGAR · Szlak Daniel
Published Jun 16, 2026, 8:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SBS
Neutral
high confidence
Mentioned
$SBS
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SBSNeutralLow
01

Why it matters

This is a disclosed ownership change by an officer. It can influence short-term sentiment, but it does not introduce new information about SABESP’s business, financial results, or outlook.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a sustained repricing without additional company catalysts.

03

What to watch

The article shows the CFO ended with 0 shares, but it does not provide context (taxes, exercise/vesting, diversification) or any concurrent company fundamentals.

Relevance 4/10Novelty 6/10Timing: Filed 2026-06-16; sale executed 2026-06-15.

Background

The article is a SEC Form 4 insider transaction: CFO Szlak Daniel sold 7,381 shares of SABESP (SBS) at $28.30 on 2026-06-15.

Company-level read

Ticker impact

$SBSNeutralHigh confidence
Context

SABESP CFO Szlak Daniel sold $208,882 of SBS shares via two open-market trades at $28.30 on 2026-06-15.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing is an officer open-market sale with no 10b5-1 plan stated and no accompanying company news (earnings, guidance, contracts, enforcement).

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated; transaction is for the issuer’s own shares.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs; without a 10b5-1 plan, the signal is still typically weak absent other disclosures.

Key entities

  • COMPANHIA DE SANEAMENTO BASICO DO ESTADO DE SAO PAULO-SABESP

    Issuer of the securities involved in the insider sale (SBS).

  • Szlak Daniel

    Chief Financial Officer who sold shares via open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

COMPANHIA DE SANEAMENTO BASICO DO ESTADO DE SAO PAULO-SABESP (SBS): Financial results for Q3 2026

COMPANHIA DE SANEAMENTO BASICO DO ESTADO DE SAO PAULO-SABESP (SBS) furnished an SEC Form 6-K — earnings release. 31 versus R$0.38 in 3Q25 • R$4.5 bn Capex in 3Q26, +13.8% y/y CEO Message In the third quarter of 2026, Sabesp continued to advance the priorities shaping the Company’s future. Our first priority is universalization, delivered safely, followed by the continued improvement of our